Efficacy of Laser Acupuncture on Pruritus in Patients With Chronic Kidney Disease Undergoing Hemodialysis

NCT ID: NCT02432508

Last Updated: 2015-05-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-10-31

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Uremic pruritus is a clinically significant symptom which imposes heavy impact on the quality of life of patients with chronic kidney disease undergoing hemodialysis. In order to investigate the clinical efficacy and mechanism, the investigators designed a multiple centers, randomized, assessor- and participant-blind, controlled, cross-over clinical trial. This trial will be conducted at Taichung branch, Feng-yuan branch and the Eastern branch of CMUH.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We plan to enroll 200 volunteer patients with uremic pruritus. After the waiting period (as the waiting list group), you will be randomized to laser acupuncture and sham laser acupuncture group. Each group will include 100 patients and given intervention according to their hemodialysis frequency, i.e., BIW or TIW. The intervention will then be crossed over to the other one after 4 week of wash-our period. Outcome measurement includes questionnaires, biochemistry analysis, instrumental analysis and medication score.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pruritus Kidney Failure, Chronic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

laser acupuncture

One hundreds of hemodialysis patients include and give intervention with laser acupuncture (50mW) for 4 weeks. After 4 weeks of wash out period, these patients cross over to shame laser acupuncture treatment (5mW).

Group Type ACTIVE_COMPARATOR

Laser acupuncture (Olympic)

Intervention Type DEVICE

Physiolaser Olympic laser acupuncture device (50mW, 655nm)

Sham Laser acupuncture (Olympic)

Intervention Type DEVICE

Physiolaser Olympic laser acupuncture device (Low dose of laser energy: 5mW, 655nm)

sham laser acupuncture

One hundreds of hemodialysis patients include and give intervention with sham laser acupuncture (5mW) for 4 weeks. After 4 weeks of wash out period, these patients cross over to laser acupuncture treatment (50mW).

Group Type SHAM_COMPARATOR

Laser acupuncture (Olympic)

Intervention Type DEVICE

Physiolaser Olympic laser acupuncture device (50mW, 655nm)

Sham Laser acupuncture (Olympic)

Intervention Type DEVICE

Physiolaser Olympic laser acupuncture device (Low dose of laser energy: 5mW, 655nm)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Laser acupuncture (Olympic)

Physiolaser Olympic laser acupuncture device (50mW, 655nm)

Intervention Type DEVICE

Sham Laser acupuncture (Olympic)

Physiolaser Olympic laser acupuncture device (Low dose of laser energy: 5mW, 655nm)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age\>20y/o, ESRD patient, pruritus symptoms persist longer than 4 weeks

Exclusion Criteria

* immunosupression agents use, undergo chemotherapy
* drug abuser
* pregnancy women
* patient with psychiological disorder
* arrhythemia, pacemaker device use
* local skin infection over laser acupuncture site
* patient allergy to laser acupuncture treament
Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

China Medical University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chang Chiz-Tzung, Ph.D.

Role: STUDY_CHAIR

School of Medicine, China Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

China Medical University Hospital

Taichung, Taichung, Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Chang Chiz-Tzung, Ph.D.

Role: CONTACT

886 0422052121 ext. 3483

Chen Hung-Chih, M.D.

Role: CONTACT

886 0422052121 ext. 3483

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Chang Chiz-Tzung, Ph.D.

Role: primary

886 0422052121 ext. 3483

References

Explore related publications, articles, or registry entries linked to this study.

Hercz D, Jiang SH, Webster AC. Interventions for itch in people with advanced chronic kidney disease. Cochrane Database Syst Rev. 2020 Dec 7;12(12):CD011393. doi: 10.1002/14651858.CD011393.pub2.

Reference Type DERIVED
PMID: 33283264 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

A-3-2-A/CMUH103-REC2-112

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Resistance Exercise in Hemodialysis Patients
NCT06604221 NOT_YET_RECRUITING NA
Light Therapy in End Stage Kidney Disease
NCT06310161 NOT_YET_RECRUITING NA